Globus Medical Inc. (GMED)

54.85
NYSE : Health Technology
Prev Close 56.21
Day Low/High 54.65 / 56.39
52 Wk Low/High 27.79 / 57.55
Avg Volume 691.70K
Exchange NYSE
Shares Outstanding 73.29M
Market Cap 5.46B
EPS 1.10
P/E Ratio 47.24
Div & Yield N.A. (N.A)

Latest News

Globus Medical Enters Trauma Market

Globus Medical Enters Trauma Market

To Showcase Portfolio of Orthopedic Trauma Products at AAOS

Globus Medical Announces Clinical Results Showing Superiority Of Its SECURE-C® To ACDF At Seven Years

Globus Medical Announces Clinical Results Showing Superiority Of Its SECURE-C® To ACDF At Seven Years

SECURE-C® long-term data confirms earlier clinical outcomes and maintains superiority

First Week Of January 2018 Options Trading For Globus Medical (GMED)

First Week Of January 2018 Options Trading For Globus Medical (GMED)

Investors in Globus Medical Inc saw new options become available this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Globus Medical Announces First Spine Surgeries Using ExcelsiusGPS™

Globus Medical Announces First Spine Surgeries Using ExcelsiusGPS™

ExcelsiusGPS™ - Robotic Trajectory Guidance and Navigation for Surgery

Globus Medical Announces First Case In Orthopedic Trauma

Globus Medical Announces First Case In Orthopedic Trauma

ANTHEM™ - Distal Radius Fracture System

Globus Medical Appoints David M. Demski As CEO

Globus Medical Appoints David M. Demski As CEO

David C. Paul to continue as Executive Chairman

Globus Medical Announces FDA 510(k) Clearance For Excelsius GPS™

Globus Medical Announces FDA 510(k) Clearance For Excelsius GPS™

Excelsius GPS™ - Robotic Trajectory Guidance and Navigation for Surgery

Short Interest In Globus Medical Moves 10% Higher

The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 877,014 share increase in total short interest for Globus Medical Inc , to 9,613,206, an increase of 10.04% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of September 15th Options Trading For Globus Medical (GMED)

First Week of September 15th Options Trading For Globus Medical (GMED)

Investors in Globus Medical Inc saw new options begin trading this week, for the September 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Globus Medical Announces CE Mark For Excelsius GPS™

Globus Medical Announces CE Mark For Excelsius GPS™

Excelsius GPS™ - Robotic Trajectory Guidance and Navigation for Surgery

Globus Medical Stock Sees Short Interest Fall 13%

Globus Medical Stock Sees Short Interest Fall 13%

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 990,027 share decrease in total short interest for Globus Medical Inc , to 6,671,333, a decrease of 12.92% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Analysts' Actions -- F5 Networks, GoPro, Lockheed Martin, U.S. Steel and More

Analysts' Actions -- F5 Networks, GoPro, Lockheed Martin, U.S. Steel and More

Here are Wednesday's top research calls, including upgrades for F5 Networks, U.S. Steel, Lockheed Martin and Sysco, and downgrades for GoPro, Kansas City Southern, Globus and Constellation Brands.

TheStreet Quant Rating: A- (Buy)